Akebia Therapeutics, Inc. (AKBA)
0.8734
-0.01
(-0.58%)
USD |
NASDAQ |
Oct 07, 16:00
0.8763
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics EPS Diluted (Quarterly) : -0.033 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.033 |
| March 31, 2026 | -0.0339 |
| December 31, 2025 | -0.0461 |
| September 30, 2025 | 0.002 |
| June 30, 2025 | 0.0009 |
| March 31, 2025 | 0.0253 |
| December 31, 2024 | -0.1043 |
| September 30, 2024 | -0.0953 |
| June 30, 2024 | -0.0409 |
| March 31, 2024 | -0.0878 |
| December 31, 2023 | 0.0032 |
| September 30, 2023 | -0.0769 |
| June 30, 2023 | -0.0598 |
| March 31, 2023 | -0.1455 |
| December 31, 2022 | -0.0501 |
| September 30, 2022 | -0.2942 |
| June 30, 2022 | 0.1547 |
| March 31, 2022 | -0.3476 |
| December 31, 2021 | -0.3978 |
| September 30, 2021 | -0.3426 |
| June 30, 2021 | -0.5147 |
| March 31, 2021 | -0.4523 |
| December 31, 2020 | -0.5995 |
| September 30, 2020 | -0.4184 |
| June 30, 2020 | -1.284 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4731 |
| December 31, 2019 | -0.7916 |
| September 30, 2019 | -0.4592 |
| June 30, 2019 | -0.4918 |
| March 31, 2019 | -0.6186 |
| December 31, 2018 | -0.8653 |
| September 30, 2018 | -0.4567 |
| June 30, 2018 | -0.60 |
| March 31, 2018 | -0.48 |
| December 31, 2017 | 0.3122 |
| September 30, 2017 | -0.49 |
| June 30, 2017 | -0.53 |
| March 31, 2017 | -1.15 |
| December 31, 2016 | -0.99 |
| September 30, 2016 | -0.96 |
| June 30, 2016 | -0.95 |
| March 31, 2016 | -0.70 |
| December 31, 2015 | -0.66 |
| September 30, 2015 | -0.68 |
| June 30, 2015 | -0.40 |
| March 31, 2015 | -0.53 |
| December 31, 2014 | -0.52 |
| September 30, 2014 | -0.47 |
| June 30, 2014 | -0.39 |
| March 31, 2014 | -43.37 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Emergent BioSolutions, Inc. | -3.492 |
| Exelixis, Inc. | 0.8166 |
| ADMA Biologics, Inc. | 0.1642 |
| Arcutis Biotherapeutics, Inc. | 0.1104 |
| Relay Therapeutics, Inc. | -0.4127 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.908M |
| Revenue (Quarterly) | 49.13M |
| Total Expenses (Quarterly) | 58.04M |
| Enterprise Value | 290.90M |
| Gross Profit Margin (Quarterly) | 77.59% |
| Profit Margin (Quarterly) | -18.13% |
| Earnings Yield | -12.71% |
| Normalized Earnings Yield | -13.56 |